Table 2. Fate of protocols according to funding*.
| Overall | PHRC 2000 | Chi2 p-value | PHRC 2000/other PHRC | Chi2 p-value | PHRC 2000/other PHRC/other funding | Chi2 p-value | |||||
| Funded | Not funded | Funded | Not funded | Funded | Not funded | ||||||
| Submitted | 481 | 101 | 380 | 138 | 343 | 175 | 306 | ||||
| Investigator response | Available | 366 | 87 (86) | 279 (73) | 123 (89) | 243 (71) | 160 (91) | 206 (67) | |||
| Not available | 115 | 14 (14) | 101 (27) | 15 (11) | 100 (29) | 15 (9) | 100 (33) | ||||
| Study initiated | No | 172 | 9 (10) | 163 (60) | <0.0001 | 15 (12) | 157 (67) | <0.0001 | 20 (13) | 152 (77) | <0.0001 |
| Yes | 185 | 77 (90) | 108 (40) | 107 (88) | 78 (33) | 139 (87) | 46 (23) | ||||
| Not provided | 9 | ||||||||||
| Study completed | No | 64 | 23 (30) | 41 (38) | 0.28 | 31 (29) | 33 (42) | 0.06 | 43 (31) | 21 (46) | 0.08 |
| Yes | 121 | 54 (70) | 67 (62) | 76 (71) | 45 (58) | 96 (69) | 25 (54) | ||||
| Study published (of those initiated) | No | 70 | 28 (37) | 42 (39) | 0.88 | 39 (37) | 31 (40) | 0.76 | 47 (34) | 23 (50) | 0.08 |
| Yes | 113 | 47 (63) | 66 (61) | 66 (63) | 47 (60) | 90 (66) | 23 (50) | ||||
| Not provided | 2 | ||||||||||
| Study published (of those completed) | No | 31 | 14 (27) | 17 (25) | 1.00 | 19 (26) | 12 (27) | 1.00 | 23 (24) | 8 (32) | 0.45 |
| Yes | 88 | 38 (73) | 50 (75) | 55 (74) | 33 (73) | 71 (76) | 17 (68) | ||||
| Not provided | 2 | ||||||||||
Values are n (%).
*Information on PHRC 2000 funding was obtained from the French Ministry of Health, information on other funding was provided by the primary investigator (327 out of 366 provided information).